Search Results - Bastos Oteiro, Mariana

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant

    COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant by Martínez-López, Joaquín, de la Cruz, Javier, Gil-Manso, Rodrigo, Yuste, Víctor Jiménez, Aspa-Cilleruelo, José María, Escobar, Cristian Escolano, López-Jiménez, Javier, Duarte, Rafael, Yerovi, Cristina Jacome, Hernández-Rivas, José-Ángel, Herráez, Regina, Quiroz-Cervantes, Keina, Bustelos-Rodriguez, Rosalía, Benavente, Celina, Martínez Barranco, Pilar, Bastos Oteiro, Mariana, Alegre, Adrián, Pérez-Oteyza, Jaime, Ruiz, Elena, Marcheco-Pupo, Eriel Alexis, Cedillo, Ángel, de Soto Álvarez, Teresa, García Ramirez, Patricia, Alonso Trillo, Rosalía, Herrera, Pilar, Bengochea Casado, María Luisa, Arroyo Barea, Andrés, Martin De Bustamante, Jose Manuel, Ortiz, Javier, Calbacho Robles, María, García-Suárez, Julio

    Published in Cancers
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    T021: Radiation‐Free Therapy as the INitial treatment of Good‐prognosis early non‐bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET‐2 ‐ RAFTING Trial

    T021: Radiation‐Free Therapy as the INitial treatment of Good‐prognosis early non‐bulky Hodgkin lymphoma, defined by a low Metabolic Tumor Volume and a negative PET‐2 ‐ RAFTING Tri... by Gallamini, Andrea, Picardi, Marco, Filonenko, Kateryna, Gotti, Manuel, Céspedes, Javier Núñez, Rossi, Andrea, Domingo‐Domènech, Eva, Giza, Agnieszka, Sorasio, Roberto, Trentin, Livio, Oteiro, Mariana Bastos, Paszkiewicz‐Kozik, Ewa, Sanz, Ramon García, Patti, Caterina, Chauvie, Stephane, Bergesio, Fabrizio, Guerra, Luca, Rambaldi, Alessandro, Balari, Ana Sureda, Zaucha, Jan Maciej

    Published in HemaSphere
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma. Interim Results of the BRESELIBET Prospective Clinical Trial

    T098: Brentuximab Vedotin plus ESHAP (BRESHAP) versus ESHAP in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma. Interim Results of the BRESELIBET Prospective Clin... by Sureda‐Balari, Anna, Terol, M. José, Domingo‐Domènech, Eva, Rodriguez, Ana Pilar González, Mohedo, Francisca Hernández, Céspedes, Javier Núñez, De La Cruz Vicente, Fátima, Muñoz, Carmen Martínez, Díaz, M. Elena Amutio, Córdoba, Raul, Izquierdo, Antonia Rodríguez, Domínguez, Samuel Romero, Meijide, Javier Briones, Greil, Richard, Velázquez, Miriam Moreno, Rubio, Araceli, Oteiro, Mariana Bastos, Gómez, Pilar, Avivi, Irit, Casanova, María, Del Campo García, Raquel, Noriega, Victor, Blanco, José Javier Sánchez, Sanz, Ramón. García

    Published in HemaSphere
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: